Optiray 350 741 mg/mL (Ioversol INJECTION) 741 mg/mL

Optiray 350 741 mg/mL is a radiocontrast agent used for imaging procedures. This injection, containing ioversol, aids in enhancing visibility during diagnostic imaging. Optiray 350 is commonly used in both intra-arterial and intravenous applications.

Strength

741 mg/mL

Pack Size

20 SYRINGE, PLASTIC in 1 CARTON (0019-1333-87) / 125 mL in 1 SYRINGE, PLASTIC

Manufacturer / TM Owner

Liebel-Flarsheim Company LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Optiray 350 741 mg/mL is primarily used as a contrast medium to improve the clarity of images during diagnostic imaging procedures. It is often administered intravenously or intra-arterially to highlight blood vessels, organs, or tissues. This helps healthcare professionals to better visualize and assess internal structures. Optiray 350 is particularly useful in procedures where detailed imaging is required, such as angiography or computed tomography (CT) scans.

Side Effects

When administered, Optiray 350 741 mg/mL may cause a temporary warming sensation or a metallic taste in the mouth. Some individuals might experience a mild headache or nausea. These effects are generally short-lived and subside quickly. Severe reactions are rare but can occur, and immediate medical attention should be sought if any unusual symptoms arise.

Precautions & Warnings

Optiray 350 741 mg/mL should be used with caution in individuals with a history of allergic reactions to contrast media. It is important to inform healthcare providers about any existing medical conditions or allergies before administration. Proper hydration is often recommended before and after the procedure to help flush the contrast agent from the body. Always follow the guidance of a healthcare professional regarding the use of this contrast medium.

Avoid Interactions

Optiray 350 741 mg/mL may interact with certain medications, particularly those that affect kidney function. It is advisable to discuss all current medications with a healthcare provider before undergoing any procedure involving this contrast agent. Additionally, individuals with kidney disease or diabetes should be monitored closely, as they may be at a higher risk of adverse effects. Alcohol and other substances that can affect kidney function should be avoided before and after the procedure.

Frequently Asked Questions

Optiray 350 741 mg/mL is used as a contrast medium to enhance the visibility of internal structures during diagnostic imaging procedures.

Optiray 350 741 mg/mL is typically administered either intravenously or intra-arterially, depending on the specific imaging procedure.

Common side effects may include a temporary warming sensation, metallic taste, mild headache, or nausea. Severe reactions are rare but require immediate medical attention.

Individuals with a history of allergic reactions to contrast media or those with kidney disease should use Optiray 350 741 mg/mL with caution and under medical supervision.

Yes, Optiray 350 741 mg/mL may interact with medications that affect kidney function. It is important to discuss all current medications with a healthcare provider before use.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.